Johnson & Johnson Unveils Next-Gen Trauma Innovations at OTA 2026
West Chester, Pennsylvania, September 22, 2026 DePuy Synthes, the orthopedic technology business of Johnson & Johnson, is showcasing a...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
West Chester, Pennsylvania, September 22, 2026 DePuy Synthes, the orthopedic technology business of Johnson & Johnson, is showcasing a...
Vancouver, British Columbia, September 23, 2026 Zymeworks Inc. has completed its previously announced acquisition of Theravance Biopharma, Inc., bringing...
